Tumorska kalcinoza prikazana kao mekotkivna tvorba u 16-godišnjeg bolesnika by Marija Milković Periša et al.
31
CASE REPORT Libri Oncol. 2017;45(1):31–34
TUMORAL CALCINOSIS PRESENTING 
AS A SOFT TISSUE MASS IN A 16 YEAR OLD PATIENT
MARIJA MILKOVIĆ PERIŠA1,4, SANDA ŠITIĆ1, IRENA VELIKI DALIĆ1, 
LJUBICA LUETIĆ CAVOR2, ILIJA GUTEŠA3 and SVEN SEIWERTH4
1 Department of Pathology, University Hospital for Tumors, 
Sestre milosrdnice University Hospital Center, Zagreb, Croatia; 
2 Department of Radiology, University Hospital for Tumors, 
Sestre milosrdnice University Hospital Center, Zagreb, Croatia; 
3 Deparment of Surgery, University Hospital for Tumors, 
Sestre milosrdnice University Hospital Center, Zagreb, Croatia; 
4 Depatment of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia
Summary
Background: Tumoral calcinosis is a rare clinicopathological condition characterized by periarticular tumor-like 
 calcium deposits most commonly found around major joints, especially the hips, shoulders and elbows. Tumoral calcinosis 
is not primarily a bone- or cartilage- forming lesion, but it can closely simulate osteocartilaginous tumors. These lesions are 
predominantly seen during the fi rst two decades of life and may be multicentric or bilateral. Laboratory analysis frequently 
shows high serum phosphate but normal serum calcium levels.
A 16 year old male presented with a huge mass in the left hip which had been growing for a month. MR detected large 
tumor mass in the left gluteal region with possible infi ltration of m.gluteus maximus. Soft tissue mass was surgically 
 resected, measuring 24 cm in diameter. Histologically, it was composed of multiple large cystic spaces with nodules of 
amorphous calcifi ed deposits surrounded by multinucleated giant cells and mononuclear infi ltrates. The lesion was poorly 
circumscribed with infi ltration into surrounding striated muscle.
Tumoral calcinosis is an uncommon and benign condition that generally occurs as a complication of trauma or renal 
dialysis, and is rarely seen in familial and sporadic cases. It can occur in a variety of clinical sett ings: primary normophos-
phatemic, primary hyperphosphatemic and secondary tumoral calcinosis occuring along with disorders that are capable of 
producing soft tissue calcifi cation. Histologically, tumoral calcinosis is characterized by amorphous calcifi ed deposits in the 
background of granulomatous appearance with multinucleated giant cells and other infl ammatory cells. The diﬀ erential 
diagnosis is broad and includes all tumoral calcinosis-like lesions that lead to abnormal dystrophic or metastatic calcium 
deposition in soft tissues. Surgical excision is the primary treatment.
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TUMORSKA KALCINOZA PRIKAZANA KAO MEKOTKIVNA TVORBA U 16-GODIŠNJEG BOLESNIKA 
– PRIKAZ SLUČAJA
Sažetak
Tumorska kalcinoza je rijetko kliničko-patološko stanje obilježeno periartikularnim kalcifi ciranim depozitima nalik 
tumorima najčešće smještenim u području kuka, ramena i lakta. Tumorska kalcinoza nije primarna bolest koštano-hrskavič-
nog sustava, iako svojim obilježjima nalikuje i upućuje na tumor koštano-hrskavičnog sustava. Izraslina se obično pojav ljuje 
multicentrično i bilateralno u prva dva desetljeća života. Laboratorijska analiza učestalo pokazuje povećanu razinu fosfata i 
normalnu razinu kalcija u serumu.
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Lječeni dječak (16 god) imao je veliku tvorbu u području lijevog kuka koja je rasla mjesecima. MR je prikazala izraslinu 
s mogućom infi ltracijom velikog glutealnog mišića. Kirurški je odstranjena neoštro ograničena tvorba najvećeg promjera 24 
cm koja je infi ltrirala strijatni mišić. Histološki je bila građena od brojnih velikih cističnih prostora s okruglastim kalcifi cira-
nim nakupinama okruženim multinuklearnim orijaškim stanicama i mononuklearnim upalnim infi ltratom.Tumorska kalci-
noza je rijetko, benigno stanje koje se uglavnom očituje kao komplikacija traume ili bubrežne dijalize, a rijetko se viđa i u 
obiteljskom i u sporadičnom obliku. Može se očitovati u nekoliko kliničkih oblika: primarna normofosfatemična, primarna 
hiperfosfatemična i sekundarna tumorska kalcinoza. Neovisno o obliku uvijek je prisutan poremećaj s nakupljanjem kalci-
fi kata u mekom tkivu.Histološki se vide amorfni kalcifi cirani depoziti okruženi granulomatoznom upalom s multinuklear-
nim orijaškim i mononuklearnim upalnim stanicama. Diferencijalna dijagnoza obuhvaća široki spektar promjena koje uklju-
čuju pretjerano distrofi čno i metastatsko nakupljanje kalcija u mekom tkivu. Kirurška ekscizija je izbor liječenja.
KLJUČNE RIJEČI: tumorska kalcinoza, radiologija, histopatološki nalaz
the characteristic TC lesions and originates from 
minimal repetitive trauma and reparative infl am-
matory process (14). Treatment for the both, fi rst 
and second group, is early surgical excision, and 
medical for third group (15,16).
CASE REPORT
A 16 year old male presented with a huge 
mass in the left hip which had been growing for a 
month. MR detected large tumor mass measuring 
18.5:13.5 cm in the left gluteal region with possible 
infi ltration of m.gluteus maximus. In dorsomedial 
part tumor extends to femoral diaphysis (Figure 
1.). On gross examination the soft tissue mass was 
solid and cystic indicating malignant soft tissue 
tumors. It was surgically resected, measuring 24 
cm in the largest diameter. Histologically, it was 
composed of multiple large cystic spaces with 
nodules of amorphous calcifi ed deposits sur-
rounded by multinucleated giant cells and mono-
nuclear infi ltrates (Figure 2. and 3.). The lesion 
was poorly circumscribed with infi ltration into 
INTRODUCTION
Tumoral calcinosis (TC) is a rare clinicopath-
ological condition characterized by calcium salt 
deposition in periarticular soft tissue. Despite this 
entity was described by Giard in 1898, Duret in 
1899 and Teutschlander in 1935, the term tumoral 
calcinosis was coined by Inclan et al in 1943 (1-4). 
The latest group of authors described essential 
pathologic features of this entity, multiple cysts 
fi lled with calcifi ed deposits lined by histiocytes, 
giant cells and xanthomatous histiocytes. This 
condition mainly manifests in childhood or ado-
lescence as tumor-like masses around the joints, 
usually in hip, shoulder and elbow region. The 
main symptoms are swelling and joint function 
limitation (4-6). On the basis of 122 reviewing 
 cases and their clinical and pathologic fi ndings, 
Smack et al divided all TCs in three groups (7). 
One group are primary normo-phosphatemic TCs 
usually presenting in fi rst two decades of life as 
solitary lesions. According to this group of au-
thors these patients are without evident familial 
connection, although recent literature detected fa-
milial connection involving mutations in the gene 
encoding SAMD9 protein (8). The second group 
are primary hyperphosphatemic TCs usually pre-
senting during the fi rst and second decades of life 
(9). This group of patients have genetic predispo-
sition with reduced urinary phosphate excretion 
caused by recessive mutations in GALNT3 and 
KLOTHO, that causes the inactivation of FGF23, a 
phosphaturic hormone (10-13). The third group 
encompasses secondary TCs connected with 
chronic renal failure (7). Despite their diﬀ erent eti-
ology and pathogenesis, histopathology is identi-
cal in all types suggesting possible common path-
way which eventually results in the formation of Figure 1. Tumor mass in the left gluteal region (MR)
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surrounding striated muscle. No signs of malig-
nancy were found.
DISCUSSION
Tumoral calcinosis is a rare benign condition. 
Fathi et Sakr reviewed the literature on tumoral 
calcinosis emphasising the importance of propa-
gating this entity to radiologists, clinicians and pa-
thologists in order to avoid a misleading impre-
cise diagnosis (17).
This entity was fi rst described in the end of 
19th century but the term was fi rst stated by Inclan 
et al in 1943. who described histopathology with 
infl ammation and dystrophic calcifi cated deposits 
implicating infl ammatory pathogenesis.(1-4). It is 
well-known that TCs can have diﬀ erent etiology, 
but interestingly histopathology of all the lesions 
is identical. According to clinical manifestation, 
TCs are divided in three groups, fi rst two groups 
comprise primary and the third one secondary 
TCs. Primary TCs either have normal or elevated 
serum phosphates but both express genetic chang-
es. The third group encompasses patients with re-
nal failure. Diagnostic problem occurs in the 
group of patients without serum or renal abnor-
malities, only presenting with periarticular tumor. 
Petscavage and Richardson presented a case of a 
young women with tumoral calcinosis mimicking 
recurrent osteosarcoma (18). The patient was ini-
tially diagnosed with osteosarcoma of the left fe-
mur and tibia at the age of 12, and after surgery 
treated with chemotherapy. At the age of 29 a new 
lesion occurred in the proximal thigh which clini-
cally and radiologically implied the recurrent tu-
mor. It is interesting that the patient had also un-
dergone dialysis due to renal failure in the end 
stage of renal disease secondary to type 1 diabe-
tes.After surgical excision and re-evaluation of the 
initial pathology report the diagnosis of tumoral 
calcinosis was established in both of the tumors. 
According to information that osteosarcoma is the 
most common primary bone malignant tumor in 
the adolescent group it is clearly that the periar-
ticular tumor mass in childhood and adolescents 
implies to malignant tumor (19). But nevertheless, 
tumoral calcinosis can appear radiographically 
similar to malignant tumors and therefore should 
be considered in diﬀ erential diagnosis.
CONCLUSION
Although tumoral calcinosis is a benign con-
dition, it represents serious clinical and radiologi-
cal problem in diﬀ erentiation from malignant 
bone tumors. These patients are usually young 
without evident or underlying clinical conditions. 
It is usually associated with familial predisposi-
tion, although usually other family members do 
not present any manifestation of the disease. 
Hereby we present a case of tumoral calcinosis in 
a young male with large tumor mass which clini-
cally and radiologically resembled malignant os-
teocartilaginous tumor. 
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